Lannion, 24 June 2025 - 5.45pm LUMIBIRD PHOTONICS SWEDEN SECURES MAJOR NAVAL CONTRACT FOR VIDAR RANGEFINDERS WITH SAAB AND DALO The Lumibird Group (FR0000038242 - LBIRD), European leader in laser technologies, announces that its subsidiary Lumibird Photonics Sweden AB has been awarded a new contract by Saab to supply 57 VIDAR laser rangefinders to the Danish Defence Acquisition and Logistics Organisation (DALO). These systems will be integrated into naval fire control systems (CEROS) deployed on Royal Danis ...

Lannion, 12 May 2025 - 5.45pm LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR SKYRANGER 30 The Lumibird Group (FR0000038242 - LBIRD), European leader in laser technologies, announces that its subsidiary Lumibird Photonics Sweden AB has received orders from Rheinmetall Air Defense (RAD) to supply Vidar laser rangefinders. These rangefinders are to be integrated into the Skyranger 30, a short-range air defense system. These orders are worth around 5 million Euro, with deliveries and contract obligations sched ...

Core Viewpoint - Lumibird Group reported a consolidated revenue growth of 12.4% in Q1 2025, reaching €49.4 million, driven by strong performance in both the Photonics and Medical divisions [1][3]. Revenue Summary - Consolidated revenues for Q1 2025 were €49.4 million, an increase of 12.4% compared to €43.9 million in Q1 2024, with a constant exchange rate growth of 11.7% [3]. - The Photonics division generated €23.9 million, up 15.8% from €20.6 million in Q1 2024, with a constant exchange rate growth of 15.1% [3][4]. - The Medical division achieved revenues of €25.5 million, reflecting a growth of 9.4% from €23.3 million in Q1 2024, with a constant exchange rate growth of 8.6% [3][6]. Division Performance - The Defence/Space business within the Photonics division saw sales rise by 37.8% to €10.5 million, attributed to multi-year contracts and order book deliveries [4]. - Industrial and Scientific sales increased by 7.0% to €5.9 million, including €0.5 million from the Continuum range acquired in October 2024 [5]. - Medtech sales slightly declined by 2.3% to €3.9 million, impacted by the timing of deliveries throughout 2025 [5]. Geographical Breakdown - EMEA revenues for Photonics were €13.8 million, up 16.2%, while Medical revenues were €7.6 million, down 6.0% [7]. - In the Americas, Photonics revenues increased by 54.1% to €4.5 million, and Medical revenues rose by 2.1% to €6.6 million [7]. - Asia-Pacific Photonics revenues decreased by 17.5% to €2.9 million, while Medical revenues increased by 29.1% to €8.1 million [7]. Future Outlook - Lumibird anticipates continued business expansion driven by growth in Defence/Space and Medical markets, with no significant impact expected from increased customs barriers [10][11].